Yatharth Hospital Raises INR 31,500 Million via 24.87% Stake Sale to Cyprus Investor Rasmalai Limited
The Competition Commission of India approves preferential issue; transaction pending further regulatory clearances
Yatharth Hospital & Trauma Care Services Limited has received Competition Commission of India approval for a preferential issue raising INR 31,500 million from Rasmalai Limited, acquiring 24.87% post-issue stake. The investment is subject to other regulatory clearances and represents a significant minority holding by the foreign investor.
Yatharth Hospital & Trauma Care Services Limited
Preferential Issue
Yatharth Hospital & Trauma Care Services Limited announced approval from the Competition Commission of India for a preferential issue to Rasmalai Limited, a Cyprus-based investor, raising approximately INR 31,500 million for a 24.87% shareholding on a fully diluted basis.
The preferential issue involves the issuance and allotment of securities on a private placement basis exclusively to Rasmalai Limited, resulting in the investor acquiring a minority stake of 24.87% post-issue in the company.
While the Competition Commission of India has given its nod on November 10, 2026, the transaction remains subject to the fulfillment of other applicable regulatory and statutory requirements.
Details regarding the timing and completion of the allotment have not been disclosed in the filing.
The company updated shareholders and the market as per SEBI disclosure norms and has published relevant documents on its website.
Highlights
- Preferential issue valued at approximately INR 31,500 million.
- Rasmalai Limited to acquire 24.87% post-issue shareholding on fully diluted basis.
- Approval obtained from Competition Commission of India dated November 10, 2026.
- Subject to other regulatory and statutory approvals before completion.
- Announcement made under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Data Snapshot
What happened
- Yatharth Hospital received approval from the Competition Commission of India for a preferential issue of equity shares.
- The issuance is made on a private placement basis to Rasmalai Limited, a Cyprus-incorporated entity.
- This investment amounts to INR 31,500 million in cash consideration.
- Post-issue, Rasmalai Limited will hold a 24.87% minority stake on a fully diluted basis.
Key details
- The transaction is subject to the fulfillment of other applicable regulatory and statutory requirements.
- No further details on the timing or sequence of completion have been disclosed.
- The announcement complies with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
- Disclosure and supporting documents are available on the company's investor relations website.
Regulatory and governance context
- The Competition Commission of India approved the preferential issue on November 10, 2026.
- This approval is required under Indian competition laws to ensure the transaction does not raise anti-competitive concerns.
- Completion depends on additional regulatory clearances beyond the CCI approval.
Highlights
- Preferential issue valued at approximately INR 31,500 million.
- Rasmalai Limited to acquire 24.87% post-issue shareholding on fully diluted basis.
- Approval obtained from Competition Commission of India dated November 10, 2026.
- Subject to other regulatory and statutory approvals before completion.
- Announcement made under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Competition Commission of India approval
More News on Preferential Issue
View allLatest corporate announcements and market updates in Preferential Issue.
Urban Company raises ₹2,500 crore in oversubscribed QIP with over ₹15,000 crore demand from marquee investors
Urban Company Limited completed a ₹2,500 crore Qualified Institutions Placement (QIP) that attracted over six times demand from marquee domestic and global institutional investors. The equity shares were allotted at ₹156 each, with strong participation from mutual funds, insurers, and global asset managers.
Read Full StoryBalu Forge Industries Proposes Increase in Authorised Share Capital to ₹132 Crore and Issues ₹162 Crore Convertible Warrants to Promoters
Balu Forge Industries Limited announced plans to increase its authorised share capital by ₹7 crore to ₹132 crore and to issue 30 lakh convertible warrants to promoters, valued at ₹162 crore, pending approval at the upcoming extraordinary general meeting (EGM) on December 12, 2026.
Read Full StoryRaymond Limited Allots Over 33 Lakh Convertible Warrants to Minerva Ventures Fund at ₹645 Each
Raymond Limited has allotted 33,28,686 convertible warrants to Minerva Ventures Fund on a preferential private placement basis at ₹645 per warrant, including a premium of ₹635. The upfront payment of ₹161.25 per warrant equates to 25% of the issue price. Upon full payment, each warrant will convert into one fully paid equity share of ₹10 face value each.
Read Full Story